Overall, Sarah A.
Toor, Jugmohit S.
Hao, Stephanie
Yarmarkovich, Mark http://orcid.org/0000-0003-4638-2019
Sara M. O’Rourke,
Morozov, Giora I.
Nguyen, Son http://orcid.org/0000-0002-0475-5158
Japp, Alberto Sada http://orcid.org/0000-0001-8106-8987
Gonzalez, Nicolas
Moschidi, Danai
Betts, Michael R.
Maris, John M.
Smibert, Peter http://orcid.org/0000-0003-0772-1647
Sgourakis, Nikolaos G.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (3UC4DK112217)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5R35CA220500, 1U54CA232568)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (5R21HG009748)
the Chan Zuckerberg Initiative
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (5R35GM125034)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (5R01AI143997)
Article History
Received: 23 May 2019
Accepted: 23 March 2020
First Online: 20 April 2020
Competing interests
: N.G.S. and P.S. are listed as inventor and co-inventor on patent applications related to the preparation of peptide-deficient MHC-I/Chaperone complexes and ECCITE-seq, respectively (US patent number WO 2020/010261 and provisional application 62/694-824). The other authors declare no competing interests.